Sally Chiu1, Paul T Williams2, Taylor Dawson1, Richard N Bergman3, Darko Stefanovski3, Steven M Watkins4, Ronald M Krauss5. 1. Children's Hospital Oakland Research Institute, Oakland, CA. 2. Lawrence Berkeley National Laboratory, Berkeley, CA. 3. Diabetes and Obesity Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA; and. 4. Lipomics (a division of Metabolon), West Sacramento, CA. 5. Children's Hospital Oakland Research Institute, Oakland, CA rkrauss@chori.org.
Abstract
BACKGROUND: Previous human studies reported inconsistent effects of dietary protein and branched-chain amino acids (BCAAs) on insulin action and glucose metabolism. Similarly, it is unclear whether saturated fat (SF) intake influences these metabolic variables. OBJECTIVE: The objective of this study was to test the effects of high [30% of energy (%E)] vs. moderate (20%E) intakes of protein (primarily whey) on insulin action and lipid and lipoprotein concentrations in the context of both high (15%E) and low (7%E) SF diets. METHODS: The study was conducted as a randomized controlled trial in 158 overweight and obese men and women. After a 4-wk baseline diet [55%E carbohydrate, 15%E protein, 30%E fat (7%E SF)], participants were randomly assigned to 4 wk of either the baseline diet or 1 of 4 test diets containing 35%E carbohydrate and either 20%E or 30%E protein and either 7%E or 15%E SF. Frequently sampled i.v. glucose tolerance tests were administered after each dietary period. RESULTS: Other than significantly higher fasting glucose concentrations for high vs. moderate protein intakes with a low-fat diet (difference ± SE: 0.47 ± 0.14 mmol/L; P = 0.001), there were no significant effects of dietary protein or SF on glucose metabolism, plasma insulin, or concentrations of lipids and lipoproteins. Changes in plasma BCAAs across all diets were negatively correlated with changes in the metabolic clearance rate of insulin (ρ = -0.18, P = 0.03) and positively correlated with changes in the acute insulin response to glucose (ρ = 0.15, P = 0.05). CONCLUSIONS: These findings suggest that short-term intake of BCAAs can influence insulin dynamics. However, in this group of overweight and obese individuals, neither high protein nor SF intake affected insulin sensitivity or plasma concentrations of lipids and lipoproteins. This trial was registered at clinicaltrials.gov as NCT00508937.
RCT Entities:
BACKGROUND: Previous human studies reported inconsistent effects of dietary protein and branched-chain amino acids (BCAAs) on insulin action and glucose metabolism. Similarly, it is unclear whether saturated fat (SF) intake influences these metabolic variables. OBJECTIVE: The objective of this study was to test the effects of high [30% of energy (%E)] vs. moderate (20%E) intakes of protein (primarily whey) on insulin action and lipid and lipoprotein concentrations in the context of both high (15%E) and low (7%E) SF diets. METHODS: The study was conducted as a randomized controlled trial in 158 overweight and obesemen and women. After a 4-wk baseline diet [55%E carbohydrate, 15%E protein, 30%E fat (7%E SF)], participants were randomly assigned to 4 wk of either the baseline diet or 1 of 4 test diets containing 35%E carbohydrate and either 20%E or 30%E protein and either 7%E or 15%E SF. Frequently sampled i.v. glucose tolerance tests were administered after each dietary period. RESULTS: Other than significantly higher fasting glucose concentrations for high vs. moderate protein intakes with a low-fat diet (difference ± SE: 0.47 ± 0.14 mmol/L; P = 0.001), there were no significant effects of dietary protein or SF on glucose metabolism, plasma insulin, or concentrations of lipids and lipoproteins. Changes in plasma BCAAs across all diets were negatively correlated with changes in the metabolic clearance rate of insulin (ρ = -0.18, P = 0.03) and positively correlated with changes in the acute insulin response to glucose (ρ = 0.15, P = 0.05). CONCLUSIONS: These findings suggest that short-term intake of BCAAs can influence insulin dynamics. However, in this group of overweight and obese individuals, neither high protein nor SF intake affected insulin sensitivity or plasma concentrations of lipids and lipoproteins. This trial was registered at clinicaltrials.gov as NCT00508937.
Authors: Timothy R Koves; John R Ussher; Robert C Noland; Dorothy Slentz; Merrie Mosedale; Olga Ilkayeva; James Bain; Robert Stevens; Jason R B Dyck; Christopher B Newgard; Gary D Lopaschuk; Deborah M Muoio Journal: Cell Metab Date: 2008-01 Impact factor: 27.287
Authors: P M Piatti; F Monti; I Fermo; L Baruffaldi; R Nasser; G Santambrogio; M C Librenti; M Galli-Kienle; A E Pontiroli; G Pozza Journal: Metabolism Date: 1994-12 Impact factor: 8.694
Authors: M F Saad; R L Anderson; A Laws; R M Watanabe; W W Kades; Y D Chen; R E Sands; D Pei; P J Savage; R N Bergman Journal: Diabetes Date: 1994-09 Impact factor: 9.461
Authors: C Christine Lee; Steve M Watkins; Carlos Lorenzo; Lynne E Wagenknecht; Dora Il'yasova; Yii-Der I Chen; Steven M Haffner; Anthony J Hanley Journal: Diabetes Care Date: 2016-02-19 Impact factor: 19.112
Authors: Nathalie Bergeron; Paul T Williams; Regina Lamendella; Nastaran Faghihnia; Alyssa Grube; Xinmin Li; Zeneng Wang; Rob Knight; Janet K Jansson; Stanley L Hazen; Ronald M Krauss Journal: Br J Nutr Date: 2016-12-20 Impact factor: 3.718
Authors: Sofia Ahola; Mari Auranen; Pirjo Isohanni; Satu Niemisalo; Niina Urho; Jana Buzkova; Vidya Velagapudi; Nina Lundbom; Antti Hakkarainen; Tiina Muurinen; Päivi Piirilä; Kirsi H Pietiläinen; Anu Suomalainen Journal: EMBO Mol Med Date: 2016-11-02 Impact factor: 12.137
Authors: Tanja V Maier; Marianna Lucio; Lang Ho Lee; Nathan C VerBerkmoes; Colin J Brislawn; Jörg Bernhardt; Regina Lamendella; Jason E McDermott; Nathalie Bergeron; Silke S Heinzmann; James T Morton; Antonio González; Gail Ackermann; Rob Knight; Katharina Riedel; Ronald M Krauss; Philippe Schmitt-Kopplin; Janet K Jansson Journal: MBio Date: 2017-10-17 Impact factor: 7.867